|
MYLIP expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.045610E-02 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.04520000046671E-07 |
| Normal-vs-Stage2 |
3.638400E-01 |
| Normal-vs-Stage3 |
5.389200E-01 |
| Normal-vs-Stage4 |
2.423900E-02 |
| Stage1-vs-Stage2 |
7.320400E-02 |
| Stage1-vs-Stage3 |
3.05599999972372E-07 |
| Stage1-vs-Stage4 |
2.05320005441934E-09 |
| Stage2-vs-Stage3 |
2.345000E-01 |
| Stage2-vs-Stage4 |
3.530400E-02 |
| Stage3-vs-Stage4 |
1.152770E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.130070E-02 |
| Normal-vs-AfricanAmerican |
3.272800E-01 |
| Normal-vs-Asian |
6.124600E-01 |
| Caucasian-vs-AfricanAmerican |
8.180000E-01 |
| Caucasian-vs-Asian |
8.443800E-01 |
| AfricanAmerican-vs-Asian |
8.064800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
6.773600E-02 |
| Normal-vs-Female |
5.760100E-03 |
| Male-vs-Female |
2.117800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.751230E-01 |
| Normal-vs-Age(41-60Yrs) |
5.415200E-04 |
| Normal-vs-Age(61-80Yrs) |
4.500200E-01 |
| Normal-vs-Age(81-100Yrs) |
7.119400E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
9.701800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.627600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.924960E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.299500E-03 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.024030E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.735600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
6.042200E-04 |
| Normal-vs-Grade 2 |
1.89840000386354E-08 |
| Normal-vs-Grade 3 |
9.291000E-01 |
| Normal-vs-Grade 4 |
1.799630E-04 |
| Grade 1-vs-Grade 2 |
1.277970E-02 |
| Grade 1-vs-Grade 3 |
5.32539999875681E-08 |
| Grade 1-vs-Grade 4 |
2.82159995368403E-09 |
| Grade 2-vs-Grade 3 |
1.79679999767757E-08 |
| Grade 2-vs-Grade 4 |
4.24882351524047E-13 |
| Grade 3-vs-Grade 4 |
5.63569999999514E-05 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
5.08482145278322E-14 |
| Normal-vs-ccB subtype |
5.783700E-03 |
| ccA subtype-vs-ccB subtype |
1.11022302462516E-16 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.701170E-01 |
| Normal-vs-N1 |
9.823300E-03 |
| N0-vs-N1 |
1.071800E-02 |
|
|
